ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,280Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 2604

$800K Total Retail Price of All Prescriptions

Rank: 45 out of 2604

492 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 13,920 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 881 708 1 2
OMEPRAZOLE 710 557 2 5
LISINOPRIL 582 442 3 3
METOPROLOL TARTRATE 513 431 4 9
METFORMIN HCL 416 356 5 7
TAMSULOSIN HCL 374 320 6 30
NEXIUM 371 319 7 53
IBUPROFEN 348 277 8 32
HYDROCODONE-ACETAMINOPHEN 343 199 S3 9 1
AMLODIPINE BESYLATE 319 264 10 6
CARVEDILOL 293 246 11 26
TRAMADOL HCL 268 215 12 15
GABAPENTIN 268 206 12 12
LEVOTHYROXINE SODIUM 262 218 14 4
FUROSEMIDE 252 199 15 8
ALENDRONATE SODIUM 248 242 16 29
RANITIDINE HCL 230 188 17 25
MELOXICAM 224 209 18 36
HYDROCHLOROTHIAZIDE 216 180 19 10
ATENOLOL 210 155 20 11
ATORVASTATIN CALCIUM 203 184 21 19
CLOPIDOGREL 195 160 22 39
CLOTRIMAZOLE-BETAMETHASONE 194 175 23 138
DONEPEZIL HCL 178 166 24 28
FAMOTIDINE 171 141 25 68
ADVAIR DISKUS 165 138 26 41
POTASSIUM CHLORIDE 163 128 27 16
GLYBURIDE-METFORMIN HCL 161 146 R 28 180
METOPROLOL SUCCINATE 155 130 29 17
PROAIR HFA 152 101 30 27
ISOSORBIDE MONONITRATE ER 152 138 30 38
WARFARIN SODIUM 147 83 32 13
PLAVIX 145 136 33 75
PROMETHAZINE HCL 142 96 R 34 88
GLIPIZIDE 132 106 35 51
GEMFIBROZIL 124 82 36 87
LIDODERM 122 93 37 80
MECLIZINE HCL 120 105 38 155
SPIRIVA 118 92 39 45
LOSARTAN POTASSIUM 114 111 40 20
TRIAMTERENE-HCTZ 108 104 41 55
SERTRALINE HCL 106 73 42 23
VOLTAREN 106 91 42 148
DIOVAN 102 86 44 123
CELEBREX 100 100 45 114
ALLOPURINOL 93 74 46 35
CRESTOR 90 81 47 47
AZITHROMYCIN 90 71 47 33
COLCRYS 88 76 49 232
ALCOHOL SWABS 87 75 50 279
HYDROCORTISONE 86 79 51 161
ZOLPIDEM TARTRATE 85 74 52 21
GLYBURIDE 84 79 R 53 83
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 54 54 22
FLUTICASONE PROPIONATE 83 77 54 31
LIPITOR 83 70 54 225
SPIRONOLACTONE 82 64 57 78
FINASTERIDE 80 80 58 103
DIGOXIN 79 71 59 71
AVODART 79 71 59 252
LACTULOSE 78 68 61 108
AMOXICILLIN 78 55 61 99
LOSARTAN-HYDROCHLOROTHIAZIDE 75 63 63 77
QUETIAPINE FUMARATE 75 71 63 66
JANUVIA 75 53 63 98
ACTOS 74 69 66 116
CEPHALEXIN 73 59 67 74
MEGESTROL ACETATE 72 71 R 68 249
PANTOPRAZOLE SODIUM 72 39 68 64
LOVASTATIN 70 56 70 24
LYRICA 70 61 70 79
LEVETIRACETAM 66 37 72 96
TRIAMCINOLONE ACETONIDE 64 43 73 125
VENTOLIN HFA 64 52 73 63
LANTUS 63 49 75 40
GLIPIZIDE XL 62 43 76 144
61 57 77 365
LANSOPRAZOLE 61 60 77 137
AMITRIPTYLINE HCL 60 32 R 79 82
INSULIN SYRINGE 59 55 80 109
CYCLOBENZAPRINE HCL 56 26 R 81 43
PROCTOZONE-HC 56 46 81 346
PROCHLORPERAZINE MALEATE 55 34 83 291
TRAZODONE HCL 55 29 83 46
PREDNISONE 52 47 85 34
DILTIAZEM 24HR ER 52 43 85 172
METOLAZONE 51 43 87 231
NAMENDA 50 30 88 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.